Home LiteratureArticle Details
PMID: 10603364 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Invasion and intracellular survival of Burkholderia cepacia.

Infection and immunity ·Vol. 68 ·No. 1 ·2000-01-00 ·Pages 24-9

Martin DW, Mohr CD

Abstract

Burkholderia cepacia has emerged as an important pulmonary pathogen in immunocompromised patients and in patients with cystic fibrosis (CF). Little is known about the virulence factors and pathogenesis of B. cepacia, although the persistent and sometimes invasive infections caused by B. cepacia suggest that the organism possesses mechanisms for both cellular invasion and evasion of the host immune response. In this study, cultured human cells were used to analyze the invasion and intracellular survival of B. cepacia J2315, a highly transmissible clinical isolate responsible for morbidity and mortality in CF patients. Quantitative invasion and intracellular growth assays demonstrated that B. cepacia J2315 was able to enter, survive, and replicate intracellularly in U937-derived macrophages and A549 pulmonary epithelial cells. Transmission electron microscopy of infected macrophages confirmed the presence of intracellular B. cepacia and showed that intracellular bacteria were contained within membrane-bound vacuoles. An environmental isolate of B. cepacia, strain J2540, was also examined for its ability to invade and survive intracellularly in cultured human cells. J2540 entered cultured macrophages with an invasion frequency similar to that of the clinical strain, but it was less invasive than the clinical strain in epithelial cells. In marked contrast to the clinical strain, the environmental isolate was unable to survive or replicate intracellularly in either cultured macrophages or epithelial cells. Invasion and intracellular survival may play important roles in the ability of virulent strains of B. cepacia to evade the host immune response and cause persistent infections in CF patients.

MeSH Terms
Burkholderia Infections/etiology Burkholderia cepacia/growth & development,isolation & purification,pathogenicity Cell Division Cell Line Cystic Fibrosis/complications Environmental Microbiology Epithelial Cells/microbiology,ultrastructure Humans Lung/microbiology,ultrastructure Macrophages/microbiology,ultrastructure Microscopy, Electron Opportunistic Infections/etiology Respiratory Tract Infections/etiology U937 Cells Virulence
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Martin D W
Department of Microbiology and Immunology, East Carolina University School of Medicine, Greenville, North Carolina 27834, USA.
Mohr C D
References (28)
28 references, click to expand
  1. Coated pits, coated vesicles, and receptor-mediated endocytosis.
    Nature. 1979 Jun 21;279(5715):679-85 PMID: 221835
  2. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.
    Johns Hopkins Med J. 1980 Nov;147(5):188-9 PMID: 7441939
  3. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.
    J Antimicrob Chemother. 1983 Jul;12 Suppl A:331-6 PMID: 6352638
  4. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
    J Pediatr. 1984 Feb;104(2):206-10 PMID: 6420530
  5. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12.
    Nature. 1985 Sep 19-25;317(6034):262-4 PMID: 2995819
  6. Antibiotic resistance of Pseudomonas species.
    J Pediatr. 1986 May;108(5 Pt 2):830-4 PMID: 3701534
  7. Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes.
    J Exp Med. 1990 Oct 1;172(4):1201-10 PMID: 2212949
  8. Microbiology of lung infection in cystic fibrosis.
    Br Med Bull. 1992 Oct;48(4):912-30 PMID: 1281036
  9. In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.
    Antimicrob Agents Chemother. 1993 Jan;37(1):123-5 PMID: 8431009
  10. Immunity to intracellular bacteria.
    Annu Rev Immunol. 1993;11:129-63 PMID: 8476559
  11. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
    J Med Microbiol. 1993 Jul;39(1):39-47 PMID: 7686977
  12. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes.
    Infect Immun. 1994 Jan;62(1):280-9 PMID: 8262640
  13. IpaB mediates macrophage apoptosis induced by Shigella flexneri.
    Mol Microbiol. 1994 Feb;11(4):619-27 PMID: 8196540
  14. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping.
    J Clin Microbiol. 1994 Apr;32(4):924-30 PMID: 7517953
  15. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.
    J Infect Dis. 1994 Dec;170(6):1524-31 PMID: 7527826
  16. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?
    J Clin Microbiol. 1995 Apr;33(4):1001-4 PMID: 7540623
  17. Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum.
    Infect Immun. 1995 Nov;63(11):4329-35 PMID: 7591067
  18. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.
    Nat Med. 1995 Jul;1(7):661-6 PMID: 7585148
  19. Occurrence of polyhydroxyalkanoic acid granule-associated proteins related to the Alcaligenes eutrophus H16 GA24 protein in other bacteria.
    FEMS Microbiol Lett. 1996 Jan 1;135(1):23-30 PMID: 8598273
  20. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    J Med Microbiol. 1996 Mar;44(3):203-10 PMID: 8636938
  21. Salmonella typhimurium invasion induces apoptosis in infected macrophages.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9833-8 PMID: 8790417
  22. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
    Microbiol Rev. 1996 Sep;60(3):539-74 PMID: 8840786
  23. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia.
    Infect Immun. 1996 Oct;64(10):4054-9 PMID: 8926068
  24. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.
    J Clin Microbiol. 1996 Dec;34(12):2914-20 PMID: 8940422
  25. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products.
    Infect Immun. 1997 Feb;65(2):617-22 PMID: 9009321
  26. Common themes in microbial pathogenicity revisited.
    Microbiol Mol Biol Rev. 1997 Jun;61(2):136-69 PMID: 9184008
  27. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes.
    Infect Immun. 1998 May;66(5):2033-9 PMID: 9573086
  28. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion.
    Infect Immun. 1999 Feb;67(2):908-13 PMID: 9916107
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2000-01-00
Pages
24-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC97097
Subset
IM
Grants
NIGMS NIH HHS · R01 GM032506 · United States
NIGMS NIH HHS · R37 GM032506 · United States
NIAID NIH HHS · AI30618 · United States
NIGMS NIH HHS · GM32506/5120MZ · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]